BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2963185)

  • 21. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on electroencephalogram (EEG) in rats suggest that moderate doses of cocaine or d-amphetamine activate D1 rather than D2 receptors.
    Ferger B; Kropf W; Kuschinsky K
    Psychopharmacology (Berl); 1994 Mar; 114(2):297-308. PubMed ID: 7838923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions.
    Arnt J; Hyttel J
    Eur J Pharmacol; 1984 Jul; 102(2):349-54. PubMed ID: 6148252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discriminative stimulus properties of cocaine in the rat using a two-choice discrete-trial avoidance paradigm.
    Ukai M; Mori E; Kameyama T
    Pharmacol Biochem Behav; 1993 Apr; 44(4):907-11. PubMed ID: 8097045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections.
    Witkin JM; Nichols DE; Terry P; Katz JL
    J Pharmacol Exp Ther; 1991 May; 257(2):706-13. PubMed ID: 1674533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discriminative stimulus properties of D1 and D2 dopamine agonists in rats.
    Kamien JB; Goldberg LI; Woolverton WL
    J Pharmacol Exp Ther; 1987 Sep; 242(3):804-11. PubMed ID: 2958620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
    Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of dopamine D1 and D2 receptor involvement in d- and l-amphetamine-induced anorexia in rats.
    Gilbert DB; Cooper SJ
    Brain Res Bull; 1985 Oct; 15(4):385-9. PubMed ID: 2933127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of dopamine D1 and D2 receptors in mediating the d-amphetamine discriminative cue.
    Furmidge LJ; Exner M; Clark D
    Eur J Pharmacol; 1991 Sep; 202(2):191-9. PubMed ID: 1687032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low level lead exposure increases sensitivity to the stimulus properties of dopamine D1 and D2 agonists.
    Cory-Slechta DA; Widzowski DV
    Brain Res; 1991 Jul; 553(1):65-74. PubMed ID: 1681979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prefrontal, accumbal [shell] and ventral striatal mechanisms in jaw movements and non-cyclase-coupled dopamine D1-like receptors.
    Adachi K; Hasegawa M; Fujita S; Lee J; Cools AR; Waddington JL; Koshikawa N
    Eur J Pharmacol; 2003 Jul; 473(1):47-54. PubMed ID: 12877937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists.
    Carlson JH; Bergstrom DA; Walters JR
    Eur J Pharmacol; 1986 Apr; 123(2):237-51. PubMed ID: 2940101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390.
    Molloy AG; Waddington JL
    Psychopharmacology (Berl); 1984; 82(4):409-10. PubMed ID: 6427836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sniffing, rearing and locomotor responses to the D-1 dopamine agonist R-SK&F 38393 and to apomorphine: differential interactions with the selective D-1 and D-2 antagonists SCH 23390 and metoclopramide.
    Molloy AG; Waddington JL
    Eur J Pharmacol; 1985 Feb; 108(3):305-8. PubMed ID: 3886407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine D2 receptor mediation of the discriminative stimulus properties of LY 171555 (quinpirole).
    Weathersby RT; Appel JB
    Eur J Pharmacol; 1986 Dec; 132(1):87-91. PubMed ID: 2949989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulus effects of d-amphetamine 1: DA mechanisms.
    Van Groll BJ; Appel JB
    Pharmacol Biochem Behav; 1992 Nov; 43(3):967-73. PubMed ID: 1360165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of D-1 receptor system on the D-2 receptor-mediated hypothermic response in mice.
    Menon MK; Gordon LI; Kodama CK; Fitten J
    Life Sci; 1988; 43(10):871-81. PubMed ID: 2901020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.
    Zarrindast MR; Poursoltan M
    Br J Pharmacol; 1989 Apr; 96(4):843-8. PubMed ID: 2663110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the stimulus properties of a pre- vs. a putative postsynaptic dose of quinpirole.
    Cory-Slechta DA; Zuch CL; Fox RA
    Pharmacol Biochem Behav; 1996 Nov; 55(3):423-32. PubMed ID: 8951984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperactivity induced by stimulation of separate dopamine D-1 and D-2 receptors in rats with bilateral 6-OHDA lesions.
    Arnt J
    Life Sci; 1985 Aug; 37(8):717-23. PubMed ID: 3927097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.